A Systematic Review of the Use of Physiological Tests Assessing the Acute Response to Treatment During Exacerbations of COPD (with a Focus on Small Airway Function)

References

• Sevenoaks MJ, Stockley RA. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity-a common inflammatory phenotype? Respir Res. 2006;7(1):70DOI:10.1186/1465-9921-7-70
   PubMedGoogle Scholar
• Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2019. Available from: http://www.goldcopd.org/.
   Google Scholar
• Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278(25):1355–1360. DOI:10.1056/NEJM196806202782501
   PubMed Web of Science ®Google Scholar
• Bosken CH, Wiggs BR, Paré PD, et al. Small airway dimensions in smokers with obstruction to airflow. Am Rev Respir Dis. 1990;142(3):563–570. DOI:10.1164/ajrccm/142.3.563
   PubMedGoogle Scholar
• Yanai M, Sekizawa K, Ohrui T, et al. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol. 1992;72(3):1016–1023. DOI:10.1152/jappl.1992.72.3.1016
   PubMed Web of Science ®Google Scholar
• Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364(9435):709–721. DOI:10.1016/S0140-6736(04)16900-6
   PubMed Web of Science ®Google Scholar
• McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–1575. DOI:10.1056/NEJMoa1106955
   PubMed Web of Science ®Google Scholar
• Stockley JA, Ismail AM, Hughes SM, et al. Maximal mid-expiratory flow detects early lung disease in α1-antitrypsin deficiency. Eur Respir J. 2017;49(3):1602055. DOI:10.1183/13993003.02055-2016
   PubMed Web of Science ®Google Scholar
• Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J. 2016;47(1):113–121. DOI:10.1183/13993003.01391-2014
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418–1422. Pt DOI:10.1164/ajrccm.157.5.9709032
   PubMed Web of Science ®Google Scholar
• Stone RM, Mortier K, Holzhauer-Barrie J, et al. COPD: Working together. National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: Clinical audit of COPD exacerbations admitted to acute hospitals in England and Wales 2017. National clinical audit report. 2018. Available from: https://www.rcplondon.ac.uk/projects/outputs/copd-working-together-clinical-audit-2017.
   Google Scholar
• Tweeddale PM, Merchant S, Leslie M, et al. Short term variability in FEV1: relation to pretest activity, level of FEV1, and smoking habits. Thorax. 1984;39(12):928–932. DOI:10.1136/thx.39.12.928
   PubMed Web of Science ®Google Scholar
• Pride NB. Tests of forced expiration and inspiration. Clin Chest Med. 2001;22(4):599–622. vii. DOI:10.1016/S0272-5231(05)70055-1
   PubMed Web of Science ®Google Scholar
• Newton MF, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest. 2002;121(4):1042–1050. DOI:10.1378/chest.121.4.1042
   PubMed Web of Science ®Google Scholar
• McNulty W, Usmani OS. Techniques of assessing small airways dysfunction. Eur Clin Respir J. 2014;1(1):25898. DOI:10.3402/ecrj.v1.25898
   PubMedGoogle Scholar
• Singh D, Long G, Cançado JED, et al. Small airway disease in chronic obstructive pulmonary disease: insights and implications for the clinician. Curr Opin Pulm Med. 2020;26(2):162–168. DOI:10.1097/MCP.0000000000000637
   PubMed Web of Science ®Google Scholar
• Stockley JA, Cooper BG, Stockley RA, et al. Small airways disease: time for a revisit? Int J Chron Obstruct Pulmon Dis. 2017;12:2343–2353. DOI:10.2147/COPD.S138540
   PubMed Web of Science ®Google Scholar
• King GG, Bates J, Berger KI, et al. Technical standards for respiratory oscillometry. Eur Respir J. 2020;55(2):1900753. DOI:10.1183/13993003.00753-2019
   PubMed Web of Science ®Google Scholar
• Borrill ZL, Houghton CM, Woodcock AA, et al. Measuring bronchodilation in COPD clinical trials. Br J Clin Pharmacol. 2005;59(4):379–384. DOI:10.1111/j.1365-2125.2004.02261.x
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097 DOI:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210DOI:10.1186/s13643-016-0384-4
   PubMedGoogle Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898DOI:10.1136/bmj.l4898
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute. Quality Assessment Tool for Before-After (Pre-Post) Studies With No Control Group. 2014. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
   Google Scholar
• Komlev AD, Kuziaev AI, Kuzenkova VE, et al. Effects of systemic glucocorticoid hormones on functional indices of the respiratory system in patients with chronic obstructive pulmonary disease during acute phase. Ter Arkh. 2007;79(3):21–25. [
   PubMed Web of Science ®Google Scholar
• Parker CM, Voduc N, Aaron SD, et al. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005;26(3):420–428. DOI:10.1183/09031936.05.00136304
   PubMed Web of Science ®Google Scholar
• Johnson MK, Birch M, Carter R, et al. Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry. Thorax. 2007;62(4):299–306. DOI:10.1136/thx.2006.061044
   PubMed Web of Science ®Google Scholar
• Stevenson NJ, Walker PP, Costello RW, et al. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172(12):1510–1516. DOI:10.1164/rccm.200504-595OC
   PubMed Web of Science ®Google Scholar
• Yetkin O, Gunen H. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease. Clin Respir J. 2008;2(1):36–40. DOI:10.1111/j.1752-699X.2007.00040.x
   PubMed Web of Science ®Google Scholar
• Jetmalani K, Timmins S, Brown NJ, et al. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission. Int J Chron Obstruct Pulmon Dis. 2015;10:939–945. DOI:10.2147/COPD.S78332
   PubMed Web of Science ®Google Scholar
• Sahn SA, Baird MD. Sahn Ee Outpatient treatment of acute bronchitis with amoxicillin in chronic obstructive pulmonary disease. Curr Ther Res Clin Exp. 1978;24(8):933–944.
   Web of Science ®Google Scholar
• Jones PW, Beeh KM, Chapman KR, et al. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014;189(3):250–255. DOI:10.1164/rccm.201310-1863PP
   PubMed Web of Science ®Google Scholar
• Tantucci C, Grassi V. Flow limitation: an overview. Monaldi Arch Chest Dis. 1999;54(4):353–357.
   PubMedGoogle Scholar
• Sapey E, Bafadhel M, Bolton CE, et al. Building toolkits for COPD exacerbations: lessons from the past and present. Thorax. 2019;74(9):898–905. DOI:10.1136/thoraxjnl-2018-213035
   PubMed Web of Science ®Google Scholar
• Papi A, Luppi F, Franco F, et al. Pathophysiology of exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(3):245–251. DOI:10.1513/pats.200512-125SF
   PubMedGoogle Scholar
• O'Donnell DE, Parker CM. COPD exacerbations. 3: pathophysiology. Thorax. 2006;61(4):354–361. DOI:10.1136/thx.2005.041830
   PubMed Web of Science ®Google Scholar
• Singh D. Small airway disease in patients with chronic obstructive pulmonary disease. Tuberc Respir Dis (Seoul)). 2017;80(4):317–324. DOI:10.4046/trd.2017.0080
   PubMed Web of Science ®Google Scholar
• Farre R, Rotger M, Montserrat JM, et al. A system to generate simultaneous forced oscillation and continuous positive airway pressure. Eur Respir J. 1997;10(6):1349–1353. DOI:10.1183/09031936.97.10061349
   PubMed Web of Science ®Google Scholar
• Borrill ZL, Houghton CM, Tal-Singer R, et al. The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD. Br J Clin Pharmacol. 2008;65(2):244–252. DOI:10.1111/j.1365-2125.2007.03013.x
   PubMed Web of Science ®Google Scholar
• Goldman MD, Saadeh C, Ross D. Clinical applications of forced oscillation to assess peripheral airway function. Respir Physiol Neurobiol. 2005;148(1-2):179–194. DOI:10.1016/j.resp.2005.05.026
   PubMed Web of Science ®Google Scholar
• Dandurand RJ, Lavoie J-P, Lands LC, the Oscillometry Harmonisation Study Group, et al. Comparison of oscillometry devices using active mechanical test loads. ERJ Open Res. 2019;5(4):00160-2019. DOI:10.1183/23120541.00160-2019
   PubMedGoogle Scholar
• Quanjer PH, Weiner DJ, Pretto JJ, et al. Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making. Eur Respir J. 2014;43(4):1051–1058. DOI:10.1183/09031936.00128113
   PubMed Web of Science ®Google Scholar